Under the microscope: Choosing the best microplate reader
Efficient microplate readers play an important role in effective hit molecule discovery. Mark Wigglesworth, of AstraZeneca, explains what he looks for in this technology.
List view / Grid view
Efficient microplate readers play an important role in effective hit molecule discovery. Mark Wigglesworth, of AstraZeneca, explains what he looks for in this technology.
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
Scientists have found a mechanism through which mutant p53 enhances metastasis by controlling tumour metabolism...
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
Scientists have shown that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by MS...
Researchers propose a novel approach to manipulate genes that may hold the key to the future of personalised medicine...
Using Raman optical technology, scientists can now produce images of brain tissue that is affected by Alzheimer’s disease...
A new protocol could be a step toward stem cell-based therapies to restore sensation in people who have lost feeling in parts of their body...
Amplifying patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies...
Researchers have identified a promising solution to improving treatments offered to patients with cystic fibrosis that could lead to the development of new personalised therapies...
Next generation sequencing sample preparation on the KingFisher platform...
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
Scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma...
An antibody treatment has been found to reduce the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant COPD...